SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-008309
Filing Date
2018-06-07
Accepted
2018-06-07 09:15:05
Documents
60
Period of Report
2018-04-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 609860
2 ex31-1.htm EX-31.1 12425
3 ex32-1.htm EX-32.1 4488
  Complete submission text file 0001493152-18-008309.txt   2611989

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE adxs-20180430.xml EX-101.INS 327442
5 XBRL SCHEMA FILE adxs-20180430.xsd EX-101.SCH 47372
6 XBRL CALCULATION FILE adxs-20180430_cal.xml EX-101.CAL 61175
7 XBRL DEFINITION FILE adxs-20180430_def.xml EX-101.DEF 87201
8 XBRL LABEL FILE adxs-20180430_lab.xml EX-101.LAB 279493
9 XBRL PRESENTATION FILE adxs-20180430_pre.xml EX-101.PRE 182022
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 18885341
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1